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RELATIONSHIP OF PASE TO MODERATE/VIGOROUS PHYSICAL ACTIVITY
MEASURED BY ACCELEROMETRY IN THE OSTEOARTHRITIS INITIATIVE
G.E. Ahn 1, J. Song 1, J. Lee 1, P.A. Semanik 1, R.W. Chang 1, L. Sharma 1,
C.B. Eaton 2, R.D. Jackson 3, A. Mysiw 4, D. Dunlop 1. 1Northwestern Univ.,
Chicago, IL, USA; 2Brown Univ., Providence, RI, USA; 3Ohio State Univ.,
Columbus, OH, USA; 4Denison Univ., Granville, OH, USA
Purpose: Physical activity conveys health beneﬁts for people with osteo-
arthritis (OA). Epidemiological studies often use self-reported instruments
to explore this relationship, but these measures do not effectively capture
actual time spent in physical activity in varying intensities. Public health
physical activity guidelines are tied to time spent in physical activity of
moderate/vigorous intensity. This study utilizes accelerometers to objec-
tively assess time spent in moderate/vigorous physical activity (MVPA) in
adults with knee OA.We investigated the correlation of objectivemeasures
with less burdensome subjective measures from Physical Activity Scale in
the Elderly (PASE) scores. We also evaluated the association of subjective
and objective measures to physical function.
Methods: Cross-sectional accelerometer data from 969 adults aged 55 and
above with radiographic knee OA (Kellgren-Lawrence  2 in one or both
knees) participating in the Osteoarthritis Initiative accelerometer moni-
toring ancillary study was assessed for physical activity and function.
Participants’ response to the PASE questionnaire was followed by 7 days of
accelerometer monitoring. Accelerometer measures included average
daily minutes in MVPA and average daily minutes in MVPA sessions of 10
minutes or more (MVPA bouts). Other subjective measures including
WOMAC (Western OntarioMacMaster) function, SF12 (12-Item Short Form
Health Survey) physical function, objective measure gait speed averaged
from two 20 meter walks, and covariables including demographics (age,
gender), and heath factors (BMI and waist circumference) were assessed.
Results:Mean PASE score was 149.80 (SD¼78.4) and mean accelerometer
MVPA was 15.55 minutes/day (SD¼17.18). PASE scores were modestly
correlated with average daily minutes in MVPA (r¼0.31) and MVPA bouts
(r¼0.21). PASE scores correlated better with accelerometer measures of
MVPA and MVPA bouts in participants who were particularly inactive
(characterized by older age, higher BMI, and greater waist circumference).
There were no signiﬁcant gender effects. Accelerometer measures of MVPA
and MVPA bouts compared to PASE scores had stronger correlation in
WOMAC function (r:-0.14, -0.12 versus -0.02), SF12 physical function
(r: 0.22, 0.19, versus 0.07), and gait speed (r: 0.35, 0.29, versus 0.16).
Conclusions: In this population with radiographic knee OA, modest
correlations of PASE with accelerometer MVPA assessments limit the
ability to use this self-reported instrument to explore relationships ofactivity intensity and OA. Accelerometry data are complementary and help
to better characterize the effects of physical activity on health outcomes.
Accelerometer MVPA and MVPA bouts were more strongly associated with
physical function than PASE, although that correlation was modest at best.
The choice of PASE versus objectivemeasurement for future epidemiologic
studies must take into account the purpose for which physical activity is
being measured.
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OSTEOARTHRITIS IN FRANCE THE COST OF AMBULATORY CARE IN 2010
L. Grange, Sr.1, F. Rannou, Sr. 2, P. Bertin, Sr. 3, C. Taieb, Sr. 4. 1Clinique
Univ.ire de Rhumatologie, CHU Grenoble, Grenoble, France; 2Dept. of
Rehabilitation, Inst. of Rheumatology, Paris, France; 3Ctr. de la douleur,
CHU Limoges, Limoges, France; 4 Publi Hlth., Boulogne Billancourt, France
Purpose: In France, the cost of an osteoarthritic patient has not been
estimated for several years. The aim of the study was to evaluate the
annual cost of the treatment given to osteoarthritic patients by GP.
Methods: The cohort was made up of patients who were diagnosed with
osteoarthritis between April 2009 and March 2010 (IMS Disease Analyzer
database) The cost includes all medical cost to the patients in the cohort,
and colligated in the Disease Analyzer database (all consultations with GPs
and all resulting drug prescriptions). The evaluated cost is therefore the
annual cost of treatment given to an osteoarthritic patient.
Results: 18 976 patients suffering from osteoarthritis were followed. For
these patients, who had an average age of 66, all consultations with GPs as
well as all resulting drug prescriptions were valued both in terms of
societal cost and cost to health insurance. The average annual cost of
disease management by a GP of a patient suffering from osteoarthritis is
therefore valued at V755 societal cost, of which around 60% (V447) is paid
by health insurance. The annual cost of treatment by a GP of a patient
suffering from hip osteoarthritis is signiﬁcantly lower at the societal level
(V715) than at the health insurance level (V425) compared to patients
suffering from osteoarthritis in the knee or elsewhere, despite their higher
age.
Conclusions: No literary data evaluating the cost of an osteoarthritic
patient currently exists. The closest data is that produced by a COART
France study (Le Pen and coll, Revue du rhumatisme, December 2005). The
prevalence of osteoarthritis has been estimated at around 4 million
sufferers, even though this ﬁgure may be conservative, we can estimate
that the cost of osteoarthritis treatment is around 3 billion euros. We are
sure that further data will be added to existing ones.
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INCIDENCE, RISK FACTORS AND CONSEQUENCES OF PERIPROSTHETIC
AND FEMORAL FRACTURE AMONG THOSE WHO SURVIVED TOTAL HIP
REPLACEMENT FOR MORE THAN A DECADE
J.N. Katz, E.A. Wright, M.B. Harris, E. Losina. Brigham and Women's Hosp.,
Boston, MA, USA
Purpose: To determine the incidence and risk factors for periprosthetic
and non-periprosthetic femoral fractures, as well as the risk of subsequent
hospitalization following these fractures, for a population-based cohort of
patients who had a total hip replacement (THR) in 1995-1996 and were
followed from 2006-2008.
Methods:We used Medicare claims data to assemble a cohort of Medicare
beneﬁciaries who had elective primary THR from July, 1995 through June,
1996. We obtained Medicare hospital claims for these patients through
2008. The ICD-9-CM code for periprosthetic fracture (996.44) was intro-
duced in October, 2005. We excluded periprosthetic fractures occurring in
the knee or shoulder region. We used the incidence density method to
calculate the annual incidence of each fracture. Time ‘at risk’ was deﬁned
from the beginning of observation (January 2006) to one of the three
events, whichever occurred ﬁrst: 1) death, 2) fracture or 3) end of the
observation period (December 2008). We used multivariate Cox propor-
tional hazards models to identify risk factors for periprosthetic fractures
and for non-implant related femoral fractures, including sex, age, race,
number of non-elective hospitalizations in the prior decade (a proxy for
comorbidity), eligibility for Medicaid (a proxy for low income) and number
Risk factors for periprosthetic and femoral fractures among Medicare recipients of primary THR
Factor Predictors of periprosthetic fracture OR (95% CI)* Predictors of femoral fracture OR (95% CI)*
Age (in 2006):<80>80 1.0 1.26 (0.95, 1.66) 1.0 1.77 (1.52, 2.07)
Sex:Male Female 1.14 (0.86, 1.51) 1.0 0.71 (0.60, 0.83) 1.0
Race:White Non-white NA** 1.97 (1.28, 3.02) 1.0
Hospitalizations 1995-2006:0-2 3-5 >5 1.0 0.99 (0.72, 1.35) 1.15 (0.79, 1.69) 1.0 1.20 (1.01, 1.41) 1.91 (1.59, 2.29)
Joint replacements after index THR and before 2006: 0 1 2 or more 1.0 1.31 (0.97, 1.75) 1.70 (1.00, 2.88) 1.0 0.60 (0.50, 0.72) 0.85 (0.62, 1.15)
* adjusted for factors on table and Medicaid eligibility ** not analyzed – too few non-Whites
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the risk of hospitalization over the next year for those patients who had
periprosthetic or femoral fracture in 2006-2007 as well as for subjects who
did not have either type of fracture.
Results: Among 58,521 Medicare beneﬁciaries who had elective primary
THR in July 1995- June 1996, 32,463 (55%) survived until January 2006.
Over the next three years, 215 (0.7%) of these patients developed a peri-
prosthetic proximal femoral fracture and 805 (2.5%) developed a femoral
fracture unrelated to a prior implant. The annual incidence of peri-
prosthetic fracture was 0.26/100 person-years and the annual incidence of
femoral fracture was 0.96/100 person-years. Older age, female sex, white
race and number of hospitalizations prior to fracture were associated with
greater risk for femoral fracture, but not for periprosthetic fracture. The
number of additional total hip or knee replacements from the index THR to
the time of fracture was associatedwith periprosthetic fracture (see Table).
Compared to those without fractures, THR recipients who sustained either
type of fracture had four-fold higher risk of hospitalization in the subse-
quent year (36% vs. 9%, p<0.0001).
Conclusions: Periprosthetic fractures do not share osteoporotic risk
factors and occur less frequently than non-implant related femoral frac-
tures, but they pose a similar burden of health care utilization. Due to the
high prevalence of THR in older persons, these fractures lead to substantial
resource use and morbidity.
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ISOKINETIC ASSESSMENT OF MUSCLE STRENGTH IN PATIENTS WITH
KNEE PAIN
R. Solà 1,2, R.-M. Valls 1, I. Martorell 1, M. Giralt 1, A. Pedret 1,3,
N. Taltavull 1,3, M. Romeu 1, À. Rodríguez 3, D. Moriña 3,
V. Lopez de Frutos 2, M. Montero 2, M. Casajuana 1,2, L. Pérez 1,2, J. Faba 1,2,
G. Bernal 1,2, A. Astilleros 1,2, R. González 1,2, C. Chetrit 4,
D. Martinez-Puig 4. 1 Facultat de Med. i Ciències de la Salut-Univ. Rovira i
Virgili, Reus, Spain; 2Hosp. Univ. Sant Joan de Reus, Reus, Spain; 3CTNS-
TECNIO-Technology Ctr. of Nutrition and Hlth., Reus, SPAIN; 4Bioiberica
S.A., Palafolls, Spain
Purpose: One of the most common joint diseases is osteoarthritis (OA) and
the knee is the most frequently affected joint in western populations.
Radiography is not a good method of diagnosis in early stages of OA, but
since knee extensor and ﬂexor strength are both lost in OA, their detection
could provide better diagnostic criteria of incipient cases.
Currently, isokinetic dynamometry measures optimal loading of the
muscles in dynamic conditions and constant preselected velocity of
movement. Hence, dynamometry is considered an objective method to
determine muscle strength. However, it is not known whether isokinetic
measurements provide knee pain information as a symptom of early OA.
Hence, our purpose was to determine: 1. Isokinetic parameters as peak
torque, total work, and muscle power of the different muscle groups
(quadriceps and hamstring) involved in mild knee pain; 2. Compare iso-
kinetic measurements between knees with mild pain vs. contra-lateral
painless knee; 3. Conduct an assessment of isokinetic measurements on
knee pain segregated by gender, age, and body mass index (BMI). 4. Assess
the reliability of isokinetic knee measurements.
Methods: Patients (n¼82) who fulﬁlled the inclusion criteria and signed
an informed consent form were included. Inclusion criteria were: age 25
and 70 years; 30 males and 50 females who suffer a mild knee pain
measured on Visual Analogue Scale (VAS) between 30 to 50 mm in eitherknee (where maximum pain perception ¼ 100 mm); Biodex System 4
isokinetic dynamometer measurement of peak torque, total work, muscle
power, mean inﬂexion and extension at 180o/s and 240o/s in painful knee
and contra-lateral knee, in males and females. The sample size was
calculated using the outcome on the isokinetic valuation of peak torque
under the speciﬁc analysis conditions of 240o/s in extension. Assuming
a standard deviation (SD) of 8.5 Newton (Nm), 80 participants are neces-
sary to detect differences of 5.5 points with a¼0.05 bilateral signiﬁcance
level, and a power of 80%.
Results: In the painful knee, the peak torque, total work andmuscle power
in ﬂexion and particularly in extension movements are reduced compared
with the contra-lateral painless knee (p<0.05). The isokinetic measure-
ments in the painless knee declined considerably with age (p<0.05). Male
muscle strength showed higher isokinetic values in the affected knee as
well as painless knee compared with female (p<0.05).
Reliability of measurement with interclass correlation coefﬁcient (ICC) for
intra-observer varied from 0.85 to 0.97 for isokinetic measurements. The
ICC inter-observer for the variable peak torque varied from 0.80 to 0.93,
reﬂecting an almost perfect ICC reliability match on the scale of Landis and
Koch.
Conclusions: Patients with mild knee pain exhibit lower isokinetic values
than the contra-lateral painless knee. This kinetic parameter can differ-
entiate between two knees (pain vs. painless) and could be a tool to
identify early knee OA. Isokinetic measurements can be a new diagnostic
tool in incipient knee OA. However, standardized reference values of iso-
kinetic measurements such as peak torque, muscle power, total work need
be deﬁned with respect to gender.
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HIGH PREVALENCE OF CARDIOVASCULAR RISK FACTORS, METABOLIC
SYNDROME AND CARDIOVASCULAR DISEASE IN PATIENTS WITH KNEE
OSTEOARTHRITIS IN A PRIMARY CARE SETTING
N. Navarro, C. Orellana, M. Moreno, C. Galisteo, J. Gratacós,
M. Larrosa. Hosp. de Sabadell (Parc Taulí), Sabadell, Spain
Patients with knee osteoarthritis (KOA), due to age, walking functional
impairment and/or a high prevalence of obesity, are at a high risk of
metabolic disorders and cardiovascular (CV) comorbidities, especially in
patients referred to tertiary centers because of advanced disease for
symptom control or surgery.
Purpose: To evaluate the frequency of metabolic disorders and CV
comorbidity in patients with symptomatic KOA referred to a rheumatolo-
gist in a primary care setting.
Methods: Consecutive patients aged >50 y referred period to a rheuma-
tology practice in a primary care setting because of symptomatic KOA
during a 12-month period. Diagnostics related to CV comorbidity and/or
glycemic or lipid disorders (hypertension, diabetes, ischemic heart disease,
heart failure, cerebrovascular disorder, venous insufﬁciency or dyslipemia)
were obtained for each patient from the computerized data base (e-cap
system) used by their family physicians. Patients with soft tissue disorders
(e.g. shoulder tendinitis, plantar fasciitis, etc) adjusted for agewere used as
control group.
Results:One hundred and eighty-four patients with KOA and 254with soft
tissue conditions were included in this cross-sectional study. Patients with
KOA but additional OA in other joints (hip, hands) were excluded. The
frequencies of hypertension, hyperglycemia/diabetes and obesity signiﬁ-
cantly higher in patients with KOA compared to the control group (Table).
